Home
>
National Drug Code (NDC)
>
Galantamine
Galantamine - 65841-757-01 - (Galantamine)
Drug Information of Galantamine
| Product NDC: | 65841-757 |
| Proprietary Name: | Galantamine |
| Non Proprietary Name: | Galantamine |
| Active Ingredient(s): | 12 mg/1 & nbsp; Galantamine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Galantamine
| Product NDC: | 65841-757 |
| Labeler Name: | Cadila Healthcare Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078898 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111010 |
Package Information of Galantamine
| Package NDC: | 65841-757-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (65841-757-01) |
NDC Information of Galantamine
| NDC Code | 65841-757-01 |
| Proprietary Name | Galantamine |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (65841-757-01) |
| Product NDC | 65841-757 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Galantamine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20111010 |
| Marketing Category Name | ANDA |
| Labeler Name | Cadila Healthcare Limited |
| Substance Name | GALANTAMINE HYDROBROMIDE |
| Strength Number | 12 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
